Results 1 to 10 of about 118,303 (321)

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy

Lancet Public Health, 2023
As the USA faces a worsening overdose crisis, improving access to evidence-based treatment for opioid use disorder (OUD) remains a policy priority. Federal regulatory changes in response to the COVID-19 pandemic substantially expanded flexibilities on ...
N. Krawczyk, Bianca D. Rivera, E. Levin, B. Dooling   +3 more
semanticscholar   +1 more source

Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.

New England Journal of Medicine, 2022
BACKGROUND Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but existing data are limited.
Elizabeth A. Suarez, K. Huybrechts, L. Straub, S. Hernández-Díaz, H. Jones, H. Connery, J. Davis, K. Gray, B. Lester, M. Terplan, H. Mogun, B. Bateman   +11 more
semanticscholar   +1 more source

Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.

JAMA psychiatry, 2022
Presents a study which aims to examine methadone-involved overdose deaths before and after federal policy in US. US Centers for Disease Control and Prevention National Vital Statistics System multiple cause of death 2019- 2020 final and 2021 provisional ...
Christopher M. Jones, W. Compton, B. Han, Grant Baldwin, N. Volkow   +4 more
semanticscholar   +1 more source

Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19

Journal of Substance Abuse Treatment, 2021
Background Due to the COVID-19 pandemic, the Substance Abuse and Mental Health Services Administration (SAMHSA) has relaxed restrictions on methadone treatment in the United States.
Sarah Brothers, A. Viera, R. Heimer
semanticscholar   +1 more source

Perioperative Methadone and Ketamine for Postoperative Pain Control in Spinal Surgical Patients: A Randomized, Double-blind, Placebo-controlled Trial

Anesthesiology, 2021
Background: Despite application of multimodal pain management strategies, patients undergoing spinal fusion surgery frequently report severe postoperative pain.
G. Murphy, M. Avram, S. Greenberg, J. Benson, S. Bilimoria, Colleen E Maher, Kevin J Teister, J. Szokol   +7 more
semanticscholar   +1 more source

Methadone is methadone

Canadian Family Physician, 2021
As a pharmacist who has been dispensing methadone for more than 20 years to patients in and out of Ontario provincial jails, I read the article by Raski et al in the November issue[1][1] with interest (and gratitude to one of the doctors on our team, who thoughtfully clipped this article out of ...
openaire   +2 more sources

Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19

medRxiv, 2020
Purpose: Methadone maintenance treatment is a life-saving treatment for people with opioid use disorders (OUD). The coronavirus pandemic (COVID-19) introduces many concerns surrounding access to opioid treatment.
M. Figgatt, Zach R. Salazar, Elizabeth Day, Louise B Vincent, N. Dasgupta   +4 more
semanticscholar   +1 more source

Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.

Drug and Alcohol Dependence, 2020
BACKGROUND Within the United States, there is a shortage of opioid treatment programs (OTPs), facilities which dispense methadone for opioid use disorder.
P. J. Joudrey, N. Chadi, P. Roy, K. Morford, P. Bach, S. Kimmel, E. Wang, S. Calcaterra   +7 more
semanticscholar   +1 more source

Sedative and antinociceptive effects of different combinations of detomidine and methadone in standing horses [PDF]

, 2017
Objective To evaluate intravenous (IV) detomidine with methadone in horses to identify a combination which provides sedation and antinociception without adverse effects. Study design Randomized, placebo-controlled, blinded, crossover.
Crosignani, N, Gozalo-Marcilla, M, Luna, S P L, Pelligand, L, Possebon, F S, Puoli Filho, J N P, Taylor, P M   +6 more
core   +2 more sources

The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. [PDF]

, 2010
This prospective patient-preference study examined the effectiveness in practice of methadone versus buprenorphine maintenance treatment and the beliefs of subjects regarding these drugs. A total of 361 opiate-dependent individuals (89% of those eligible,
Holland, R, Maskrey, V, Pinto, H, Rumball, D, Swift, L, Wagle, A   +5 more
core   +1 more source